𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Androgen blockade in prostate cancer

✍ Scribed by Fernand Labrie; Bernard Candas

Book ID
117293244
Publisher
The Lancet
Year
2000
Tongue
English
Weight
53 KB
Volume
356
Category
Article
ISSN
0140-6736

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Androgen blockade in prostate cancer
Androgen blockade in prostate cancer
✍ Otilia Dalesio; Harm van Tinteren; Richard Peto; Mike Clarke; Fritz H SchrΓΆder πŸ“‚ Article πŸ“… 2000 πŸ› The Lancet 🌐 English βš– 61 KB
Monotherapy versus combined androgen blo
Monotherapy versus combined androgen blockade in patients with advanced prostate cancer
✍ Abelardo Errejon; E. David Crawford πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 33 KB

Despite a number of large randomized clinical trials, there still is uncertainty regarding the value of maximal androgen blockade in the treatment of patients with advanced prostate carcinoma. In the referenced article, the authors provide a very comprehensive review of the literature concerning one

IncreasedRB1 abnormalities in human prim
IncreasedRB1 abnormalities in human primary prostate cancer following combined androgen blockade
✍ Mack, Philip C.; Chi, Sung-Gil; Meyers, Frederick J.; Stewart, Susan L.; deVere πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 196 KB

BACKGROUND. The RB1 proliferation control pathway is a critical determinant of cell cycle progression. Abnormalities of RB1 are found in a variety of cancers, and the association with human prostate cancer (CaP) was examined here. METHODS. RNA expression levels of RB1 in CaPs were examined by RT-PCR